Construction and Validation of Novel Ferroptosis-related Risk Score Signature and Prognostic Prediction Nomogram for Patients with Colorectal Cancer

Overview

Journal Int J Med Sci

Specialty General Medicine

Date 2024 May 22

PMID 38774759

Authors

Ruibin Liu

Yue Wang

Jiawen Bu

Qingqing Li

Fang Chen

Mengying Zhu

Huanyu Chi

Guilin Yu

Tong Zhu

Xudong Zhu

Guohua Zhao

Affiliations

Soon will be listed here.

Abstract

Colorectal cancer (CRC) has a high morbidity and mortality. Ferroptosis is a phenomenon in which metabolism and cell death are closely related. The role of ferroptosis-related genes in the progression of CRC is still not clear. Therefore, we screened and validated the ferroptosis-related genes which could determine the prevalence, risk and prognosis of patients with CRC. We firstly screened differentially expressed ferroptosis-related genes by The Cancer Genome Atlas (TCGA) database. Then, these genes were used to construct a risk-score model using the least absolute shrinkage and selection operator (LASSO) regression algorithm. The function and prognosis of the ferroptosis-related genes were confirmed using multi-omics analysis. The gene expression results were validated using publicly available databases and qPCR. We also used publicly available data and ferroptosis-related genes to construct a prognostic prediction nomogram. A total of 24 differential expressed genes associated with ferroptosis were screened in this study. A three-gene risk score model was then established based on these 24 genes and GPX3, CDKN2A and SLC7A11 were selected. The significant prognostic value of this novel three-gene signature was also assessed. Furthermore, we conducted RT-qPCR analysis on cell lines and tissues, and validated the high expression of CDKN2A, GPX3 and low expression of SLC7A11 in CRC cells. The observed mRNA expression of GPX3, CDKN2A and SLC7A11 was consistent with the predicted outcomes. Besides, eight variables including selected ferroptosis related genes were included to establish the prognostic prediction nomogram for patients with CRC. The calibration plots showed favorable consistency between the prediction of the nomogram and actual observations. Also, the time-dependent AUC (>0.7) indicated satisfactory discriminative ability of the nomogram. The present study constructed and validated a novel ferroptosis-related three-gene risk score signature and a prognostic prediction nomogram for patients with CRC. Also, we screened and validated the ferroptosis-related genes GPX3, CDKN2A, and SLC7A11 which could serve as novel biomarkers for patients with CRC.

References

Biller L, Schrag D . Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. JAMA. 2021; 325(7):669-685. DOI: 10.1001/jama.2021.0106. View

McCarthy D, Chen Y, Smyth G . Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res. 2012; 40(10):4288-97. PMC: 3378882. DOI: 10.1093/nar/gks042. View

Phipps O, Brookes M, Al-Hassi H . Iron deficiency, immunology, and colorectal cancer. Nutr Rev. 2020; 79(1):88-97. DOI: 10.1093/nutrit/nuaa040. View

Zhao H, Li J, Li X, Han C, Zhang Y, Zheng L . Silencing GPX3 Expression Promotes Tumor Metastasis in Human Thyroid Cancer. Curr Protein Pept Sci. 2015; 16(4):316-21. DOI: 10.2174/138920371604150429154840. View

Subramanian A, Tamayo P, Mootha V, Mukherjee S, Ebert B, Gillette M . Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102(43):15545-50. PMC: 1239896. DOI: 10.1073/pnas.0506580102. View

Koleini N, Shapiro J, Geier J, Ardehali H . Ironing out mechanisms of iron homeostasis and disorders of iron deficiency. J Clin Invest. 2021; 131(11). PMC: 8159681. DOI: 10.1172/JCI148671. View

Hassannia B, Vandenabeele P, Vanden Berghe T . Targeting Ferroptosis to Iron Out Cancer. Cancer Cell. 2019; 35(6):830-849. DOI: 10.1016/j.ccell.2019.04.002. View

Wei R, Zhao Y, Wang J, Yang X, Li S, Wang Y . Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells. Int J Biol Sci. 2021; 17(11):2703-2717. PMC: 8326123. DOI: 10.7150/ijbs.59404. View

Wang Y, Yu L, Ding J, Chen Y . Iron Metabolism in Cancer. Int J Mol Sci. 2018; 20(1). PMC: 6337236. DOI: 10.3390/ijms20010095. View

10.

Haug U, Poole E, Xiao L, Curtin K, Duggan D, Hsu L . Glutathione peroxidase tagSNPs: associations with rectal cancer but not with colon cancer. Genes Chromosomes Cancer. 2012; 51(6):598-605. PMC: 3523169. DOI: 10.1002/gcc.21946. View

11.

Lei S, Chen C, Han F, Deng J, Huang D, Qian L . AMER1 deficiency promotes the distant metastasis of colorectal cancer by inhibiting SLC7A11- and FTL-mediated ferroptosis. Cell Rep. 2023; 42(9):113110. DOI: 10.1016/j.celrep.2023.113110. View

12.

Sturm G, Finotello F, Petitprez F, Zhang J, Baumbach J, Fridman W . Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology. Bioinformatics. 2019; 35(14):i436-i445. PMC: 6612828. DOI: 10.1093/bioinformatics/btz363. View

13.

Zhang Y, Shi J, Liu X, Feng L, Gong Z, Koppula P . BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol. 2018; 20(10):1181-1192. PMC: 6170713. DOI: 10.1038/s41556-018-0178-0. View

14.

Martino E, Balestrieri A, Aragona F, Bifulco G, Mele L, Campanile G . MiR-148a-3p Promotes Colorectal Cancer Cell Ferroptosis by Targeting SLC7A11. Cancers (Basel). 2023; 15(17). PMC: 10486764. DOI: 10.3390/cancers15174342. View

15.

Mou Y, Zhang Y, Wu J, Hu B, Zhang C, Duan C . The Landscape of Iron Metabolism-Related and Methylated Genes in the Prognosis Prediction of Clear Cell Renal Cell Carcinoma. Front Oncol. 2020; 10:788. PMC: 7256878. DOI: 10.3389/fonc.2020.00788. View

16.

Gao B, Li X, Li S, Wang S, Wu J, Li J . Pan-cancer analysis identifies RNA helicase DDX1 as a prognostic marker. Phenomics. 2023; 2(1):33-49. PMC: 9590584. DOI: 10.1007/s43657-021-00034-x. View

17.

Briggs K, Koivunen P, Cao S, Backus K, Olenchock B, Patel H . Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine. Cell. 2016; 166(1):126-39. PMC: 4930557. DOI: 10.1016/j.cell.2016.05.042. View

18.

Li S, Lu Z, Sun R, Guo S, Gao F, Cao B . The Role of SLC7A11 in Cancer: Friend or Foe?. Cancers (Basel). 2022; 14(13). PMC: 9264807. DOI: 10.3390/cancers14133059. View

19.

Zhang Q, Deng T, Zhang H, Zuo D, Zhu Q, Bai M . Adipocyte-Derived Exosomal MTTP Suppresses Ferroptosis and Promotes Chemoresistance in Colorectal Cancer. Adv Sci (Weinh). 2022; 9(28):e2203357. PMC: 9534973. DOI: 10.1002/advs.202203357. View

20.

Liu S, Yue M, Lu Y, Wang Y, Luo S, Liu X . Advancing the frontiers of colorectal cancer treatment: harnessing ferroptosis regulation. Apoptosis. 2023; 29(1-2):86-102. DOI: 10.1007/s10495-023-01891-9. View